NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1164630679 MD
Verify on CMS → Sudhir Manda, MD
Hematology & Oncology Physician in Tucson, Arizona.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
794
Medicare Part D claims · 171 beneficiaries · Hematology & Oncology Physician avg: 885
MIPS score
99.6/100
▲ 16 pts above national avg 83.5 · Exceptional
Industry payments
$1.7K
94 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Sudhir Manda, MD reported a CMS MIPS final score of 99.6/100 - above the 83.5 national average - and filed 794 Medicare Part D claims in 2024.
- 99.6/100
- MIPS score · +16 vs avg
- 794
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥91st
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Sudhir Manda, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1164630679), first enumerated 05/18/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 794 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 99.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.7K in reported industry payments (94 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1164630679 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ELITE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1164630679
- ENUM-MID 2007
- TAX-MID 12K Hematology &
- MIPS-ELITE 99.6/100
- RX-LIGHT 794
- BOOK-THIN 241 in Arizona
- PHOTO-FINISH Cynthia Shepherd, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Donald Wender, M…
Donald Wender, M.D.
99.5 MIPS pts
- Manda · this pro…
Manda · this provider
99.6 MIPS pts
- Estelamari Rodri…
Estelamari Rodriguez, MD
99.6 MIPS pts
- William Jonas, M…
William Jonas, M.D.
99.6 MIPS pts
- Cynthia Shepherd…
Cynthia Shepherd, MD
99.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Sudhir Manda, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
100 ≥ 91st percentile 91% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Sudhir Manda, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sudhir Manda, MD writes more Part D claims than 53% of them and scores higher on MIPS quality than 91% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Sudhir Manda, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Sudhir Manda, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sudhir Manda, MD?
High performer (top quartile)Primary specialty
Hematology & Oncology Physician
Medicare Part D claims
794 10% vs specialty avg
MIPS final score
99.6/100 16.1 pts vs avg
Specialty distribution in Arizona
How Hematology & Oncology Physician compares to other specialties among Arizona providers
Medicare quality performance, MIPS
Sudhir Manda, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 99.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1164630679 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/18/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
99.5827
Final Score
Measured-score avg: 83.5
92.21
Quality
100
Promoting Interoperability
Reporting: Individual
Hospital and facility affiliations
Facilities where Sudhir Manda, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Tmc Medical Network
Tucson, AZ
Tmcone
Tucson, AZ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sudhir Manda, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.7K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
794
Total Claims
$4.0M
Total Drug Cost
171
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 930.567
- Total Day Supply
- 22,346
- Generic Drug Cost
- $747K
- Opioid Claims
- 36 (4.5% rate)
- Antibiotic Claims
- 52
Patient Demographics
- Average Patient Age
- 74.8 years
- Avg HCC Risk Score
- 2.30
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 11, 65-74: 69, 75-84: 68, 85+: 23
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Sudhir Manda, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Acyclovir
Acyclovir
88 claims
- Revlimid
Revlimid
70 claims
- Prochlorperazine M…
Prochlorperazine Maleate
64 claims
- Lenalidomide
Lenalidomide
55 claims
- Ondansetron Hcl
Ondansetron Hcl
40 claims
- Ondansetron Odt 34
Ondansetron Odt
34 claims
- Pomalyst 31
Pomalyst
31 claims
- Calquence 26
Calquence
26 claims
| Drug | Claims |
|---|---|
| Acyclovir | 88 |
| Revlimid Lenalidomide | 70 |
| Prochlorperazine Maleate | 64 |
| Lenalidomide | 55 |
| Ondansetron Hcl | 40 |
| Ondansetron Odt Ondansetron | 34 |
| Pomalyst Pomalidomide | 31 |
| Calquence Acalabrutinib Maleate | 26 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 26 |
| Eliquis Apixaban | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Sudhir Manda, MD fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Sudhir Manda, MD's 794 claims are below the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Manda, both outside Arizona so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (99.6 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Manda.
One of 241 Hematology & Oncology Physician providers enrolled in Arizona, 5 are shown here.
Dr. Ahmed Abdelaziz
M.D.
Tucson, AZ
Oluseyi Abidoye
Phoenix, AZ
Dr. Roberta Adams
M.D.
Scottsdale, AZ
Dr. Clarence Adoo
M.D.
Peoria, AZ
Dr. Yusuf Ahmad
M.D.
Oro Valley, AZ
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Sudhir Manda, MD's specialty? ▼
Sudhir Manda, MD specializes in Hematology & Oncology Physician and practices in Tucson, Arizona. Credentials: MD.
How much does Sudhir Manda, MD prescribe under Medicare Part D? ▼
In 2024, Sudhir Manda, MD wrote 794 Medicare Part D claims totaling $4.0M in drug costs for 171 beneficiaries.
What is Sudhir Manda, MD's Medicare quality score? ▼
Sudhir Manda, MD has a CMS MIPS Final Score of 99.6/100 (Quality: 92.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Sudhir Manda, MD located? ▼
Sudhir Manda, MD is located at 603 N WILMOT RD, Tucson, AZ, 85711. Phone: (520) 886-0206.
What is Sudhir Manda, MD's NPI number? ▼
Sudhir Manda, MD's National Provider Identifier (NPI) is 1164630679, issued on 05/18/2007.
Does Sudhir Manda, MD prescribe opioids? ▼
Yes, Sudhir Manda, MD had 36 opioid claims in 2024 with an opioid prescribing rate of 4.5%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Sudhir Manda, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Sudhir Manda, MD's most frequently prescribed drugs include Acyclovir, Revlimid, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sudhir Manda, MD accept Medicare? ▼
Sudhir Manda, MD appears in CMS Medicare data with 794 Part D claims and 171 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sudhir Manda, MD's credentials? ▼
Sudhir Manda, MD's NPI is 1164630679 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.